"GTC downsizes, gets $7m in financing" by Associated Press | June 17, 2010
FRAMINGHAM — GTC Biotherapeutics says it is restructuring and downsizing its operations even as it secures $7 million in debt financing from its French strategic partners.
GTC said yesterday that its chief executive, Geoffrey Cox, and several other senior managers will be leaving the Framingham company, which produces drugs from the milk of genetically engineered animals.
And down the drain it goes.
Looks like it is going to be a long night, readers.
(Woke up before it ended and Globe never told me the result of the hearing).